Maria Meritxell Roca Mora: DOACs Show Promise Over VKAs in Kidney Transplant Recipients
Meta Analysis Academy shared on X:
”New Meta Master Publication Alert
A systematic review and Meta-Analysis of 5 studies (n=959 patients) compared direct-acting oral anticoagulants (DOACs) vs. vitamin K antagonists (VKAs) in kidney transplant recipients (KTRs).
Key findings:
- DOACs reduced major bleeding
- DOACs lowered mortality
- No significant difference in VTE risk, in graft failure and kidney function (eGFR)
Conclusion: DOACs may be an effective anticoagulation strategy in KTRs, offering reduced bleeding and mortality compared with VKAs, though evidence quality remains low-to-moderate.”
Read the full article here.
Article: Safety and efficacy of direct oral anticoagulants in kidney transplant recipients: A systematic review and meta-analysis
Authors: Maria Meritxell Roca Mora, Andre Milani Reis, Filipe Piazzi Tavares, Lídia Santos Oliveira, Amanda Godoi, Patricia Viana, Juliano Riella
Stay updates on the latest advances in the field of anticoagulation with Hemostasis Today.
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy
-
Dec 14, 2025, 16:06Dr Abdul Mannan: What’s Your Approach to Diagnosing Iron Deficiency in Tricky Cases?